Government Changes Rules to Make Doing Business Easier for Pharma and Food Companies

Date:

Share post:

In a major step toward trust-based governance, the Government of India has operationalised key reforms under the Jan VishwasAct, 2026. The initiative rationalises minor offences under the Drugs and Cosmetics Act, 1940, and the Food Safety and Standards Act, 2006, significantly reducing the compliance burden for businesses while protecting public health.

The landmark reforms decriminalise minor, technical, and procedural violations such as basic record-keeping gaps or minor cosmetic labelling errors,replacing criminal proceedings with administrative penalties. Notably, Section 29 of the Drugs and Cosmetics Act has been completely omitted. For food safety, duplicate provisions regarding obstructing officers have been removed to align with the Bharatiya Nyaya Sanhita (BNS). To ensure smooth implementation, the government has introduced dedicated Adjudicating Authorities and a transparent appeal mechanism.

Crucially, the Ministry of Health and Family Welfare emphasized that strict criminal laws remain firmly in place for serious offences involving spurious or adulterated products that risk consumer safety. This balanced approach slashes unnecessary legal hurdles for compliant businesses, fostering a modern, transparent, and highly efficient regulatory ecosystem in India’s food and pharma sectors.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...